Half-year report · HY
9438.TEDINET S100Y47X
Period2025-10-01 → 2026-03-31
Filed2026-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥15.7bn | 2025-10-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥29.9bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.9bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Operating income | ¥1.7bn | 2025-10-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥1.6bn | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥2.1bn | 2025-10-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.0bn | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.7bn | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.1bn | 2025-10-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.5bn | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.9bn | 2025-10-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.4bn | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.8bn | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.9bn | 2025-10-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥1.8bn | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥32.0bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥33.3bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥30.7bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.6bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥10.9bn | at 2025-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥23.4bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥22.4bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥20.6bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥15.1bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥17.8bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥15.1bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥17.8bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.2bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.8bn | at 2024-09-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥310m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.7bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.0bn | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥996m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.7bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥789m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.4bn | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥943m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥770m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥33.58 | 2025-10-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.62 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.87 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥61.55 | 2024-10-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥31.82 | 2024-10-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 61.9% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.2% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 45
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-10-01 → 2026-03-31 | −¥860m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-10-01 → 2026-03-31 | −¥860m |
| Reconciling Itemsreconciling | segment profit | 2025-10-01 → 2026-03-31 | −¥1.3bn |
| Content Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥8.4bn |
| Content Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥8.3bn |
| Content Businessreportable segment | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥135m |
| Content Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥2.2bn |
| Healthcare Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥3.9bn |
| Healthcare Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥3.9bn |
| Healthcare Businessreportable segment | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥4m |
| Healthcare Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | −¥254m |
| Other Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥3.1bn |
| Other Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥2.3bn |
| Other Businessreportable segment | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥715m |
| Other Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥620m |
| School DX Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥1.1bn |
| School DX Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥1.1bn |
| School DX Businessreportable segment | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥6m |
| School DX Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥410m |
| —segment total | revenue | 2025-10-01 → 2026-03-31 | ¥16.5bn |
| —segment total | revenue external | 2025-10-01 → 2026-03-31 | ¥15.7bn |
| —segment total | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥860m |
| —segment total | segment profit | 2025-10-01 → 2026-03-31 | ¥3.0bn |
| Reconciling Itemsreconciling | revenue | 2024-10-01 → 2025-03-31 | −¥723m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-10-01 → 2025-03-31 | −¥723m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥1.3bn |
| Content Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥8.7bn |
| Content Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥8.5bn |
| Content Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥108m |
| Content Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥2.0bn |
| Healthcare Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥3.2bn |
| Healthcare Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥3.1bn |
| Healthcare Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥5m |
| Healthcare Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥87m |
| Other Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥2.9bn |
| Other Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥2.3bn |
| Other Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥609m |
| Other Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥629m |
| School DX Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥904m |
| School DX Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥904m |
| School DX Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥272m |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥15.6bn |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥14.9bn |
| —segment total | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥723m |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | ¥3.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 541
| Item | Context | Value | Unit |
|---|---|---|---|
| Other ncl | InterimInstant | 41861000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 2827438000 | JPY |
| Noncurrent liabilities | InterimInstant | 2539192000 | JPY |
| Liabilities | Prior1YearInstant | 10901628000 | JPY |
| Liabilities | InterimInstant | 8589750000 | JPY |
| Capital stock | Prior1YearInstant | 5511199000 | JPY |
| Capital stock | InterimInstant | 5530430000 | JPY |
| Capital surplus | Prior1YearInstant | 6317535000 | JPY |
| Capital surplus | InterimInstant | 6319270000 | JPY |
| Retained earnings | Prior1YearInstant | 8709727000 | JPY |
| Retained earnings | InterimInstant | 9989600000 | JPY |
| Treasury stock | Prior1YearInstant | -2596900000 | JPY |
| Treasury stock | InterimInstant | -2571178000 | JPY |
| Shareholders equity | Prior1YearInstant | 17941562000 | JPY |
| Shareholders equity | InterimInstant | 19268122000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 195642000 | JPY |
| Valuation difference on available for sale securities | InterimInstant | 218900000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 57021000 | JPY |
| Foreign currency translation adjustment | InterimInstant | 108970000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 219696000 | JPY |
| Remeasurements of defined benefit plans | InterimInstant | 206821000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 472360000 | JPY |
| Valuation and translation adjustments | InterimInstant | 534691000 | JPY |
| Non controlling interests | Prior1YearInstant | 4032203000 | JPY |
| Non controlling interests | InterimInstant | 3586739000 | JPY |
| Net assets | Prior1YearInstant | 22446125000 | JPY |
| Net assets | InterimInstant | 23389553000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 33347754000 | JPY |
| Liabilities and net assets | InterimInstant | 31979304000 | JPY |
| Net sales | Prior1InterimDuration | 14885366000 | JPY |
| Net sales | InterimDuration | 15666453000 | JPY |
| Cost of sales | Prior1InterimDuration | 3793689000 | JPY |
| Cost of sales | InterimDuration | 4206645000 | JPY |
| Gross profit | Prior1InterimDuration | 11091676000 | JPY |
| Gross profit | InterimDuration | 11459807000 | JPY |
| Selling general and administrative expenses | Prior1InterimDuration | 9451775000 | JPY |
| Selling general and administrative expenses | InterimDuration | 9780008000 | JPY |
| Operating income | Prior1InterimDuration | 1639901000 | JPY |
| Operating income | InterimDuration | 1679799000 | JPY |
| Interest income noi | Prior1InterimDuration | 1416000 | JPY |
| Interest income noi | InterimDuration | 4043000 | JPY |
| Equity in earnings of affiliates noi | Prior1InterimDuration | 92216000 | JPY |
| Equity in earnings of affiliates noi | InterimDuration | 403190000 | JPY |
| Other noi | Prior1InterimDuration | 11302000 | JPY |
| Other noi | InterimDuration | 9085000 | JPY |
| Non operating income | Prior1InterimDuration | 104936000 | JPY |
| Non operating income | InterimDuration | 416319000 | JPY |
| Interest expenses noe | Prior1InterimDuration | 8510000 | JPY |
| Interest expenses noe | InterimDuration | 9062000 | JPY |
| Foreign exchange losses noe | Prior1InterimDuration | 1170000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |